Hereditary angioedema: HAE
Conditions
Interventions
None listed
Sponsors
CSL Behring K.K
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Participants must meet all of the following inclusion criteria: 1)Female or male aged >= 12 years, as the date of responding to the survey 2)Self-reported to have been diagnosed with HAE by a physician 3)Able to provide informed consent to participate in the study and willing to participate in the study
Exclusion criteria
Exclusion criteria: Participants who meet any of the following exclusion criteria will be excluded from participation in this study: 1)Participants who are not members of either the HAEJ or CREATE patient groups 2)Participants who have already responded to this study via the other patient group
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The impact and degree that HAE affects anxiety and depression as well as angioedema-related quality of life (QoL) in Japanese HAE patients: HADS, AE-QoL | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)The treatment satisfaction in Japanese HAE patients:TSQM-9 2)The impact of HAE on the work productivity and generic health status in Japanese HAE patients:EQ-5D-5L,WPAI-GH 3)Patients' most important factor for deciding medication preference for HAE in Japanese patients 4)The impacts of the demographics, clinical and disease characteristics on HADS in Japanese HAE patients | — |
Countries
Japan
Contacts
Public ContactHikaru Onishi
INTAGE Healthcare Inc Value & Access Department
Outcome results
None listed